MedCity's conferences this year include a new population health event in New Orleans and a collaboration with HLTH that will see our annual patient engagement conference integrated into HLTH's larger event. The season kicks off April 23 with our annual MedCity INVEST event in Chicago.
Not only have a significant number of entrepreneurs had successful exits, but they are going on to start their next healthcare ventures in the Philadelphia area.
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
Panelists highlight Roche's acquisition of Flatiron Health in February and use of AI/ML in drug development.
At MedCity CONVERGE on July 12, panelists discussed rising oncology costs and posed questions about how the nation is spending its healthcare dollars.
Panel at MedCity CONVERGE discussed the practical applications of AI in the treatment of cancers.
At the MedCity CONVERGE conference, medical oncologist Dr. Joshua Brody, the director of the lymphoma immunotherapy program at Mount Sinai Hospital, talked about some of the hype and hope of CAR-T and checkpoint blockade immunotherapy treatments.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
At the MedCity CONVERGE conference in Philadelphia on July 11, experts from Harvard Business School, payer Highmark and tech company Integra Connect explored how their organizations are approaching the intersection of cancer and value-based care.
AstraZeneca subsidiary and California-based firm to develop AAV-based therapy for chronic lung disease.
A conversation with investor Gary Kurtzman.
The Takeda Ventures Senior Partner will take part in the panel discussion Trends in Oncology Investing at the MedCity CONVERGE Conference July 11-12 in Philadelphia.
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.
As the MedCity CONVERGE conference in Philadelphia July 11-12 approaches, here's a look at the innovation that's taking root in the cancer care and precision medicine sectors presented by health IT and life science entrepreneurs.
Michael Pellini, the featured speaker at MedCity's CONVERGE conference next month, holds forth on his new VC gig at Bill Maris-founded Section 32, the practice of oncology, and how healthcare must get more tightly integrated with tech.
The Philadelphia event from July 11-12 highlights the most compelling topics in healthcare from breaking down the data silos in cancer research, how to scale precision medicine, the reimbursement hurdles for genetic testing, AI applications and investment trends in oncology and precision medicine.
Meteorologists usually enlist the help of a huge supercomputer when they run their weather models.
In his role as senior VP and managing director of Safeguard Scientifics, a venture capital firm based just outside Philadelphia, Gary Kurtzman leads the firm’s healthcare investments. So he’s perhaps a bit biased when he says that Philadelphia is the “center of the healthcare universe,” as he did in a 2016 interview.